|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kalogeridi MA, Zygogianni A, Kyrgias G,
Kouvaris J, Chatziioannou S, Kelekis N and Kouloulias V: Role of
radiotherapy in the management of hepatocellular carcinoma: A
systematic review. World J Hepatol. 7:101–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khemlina G, Ikeda S and Kurzrock R: The
biology of Hepatocellular carcinoma: Implications for genomic and
immune therapies. Mol Cancer. 16:1492017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartha I, di Iulio J, Venter JC and
Telenti A: Human gene essentiality. Nat Rev Genet. 19:51–62. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiong DD, Dang YW, Lin P, Wen DY, He RQ,
Luo DZ, Feng ZB and Chen G: A circRNA-miRNA-mRNA network
identification for exploring underlying pathogenesis and therapy
strategy of hepatocellular carcinoma. J Transl Med. 16:2202018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang B, Liu Z, Cao K, Shan W, Liu J, Wen
Q and Wang R: circ-SPECC1 modulates TGFβ2 and autophagy under
oxidative stress by sponging miR-33a to promote hepatocellular
carcinoma tumorigenesis. Cancer Med. 9:5999–6008. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Afify AY, Ibrahim SA, Aldamsisi MH,
Zaghloul MS, El-Ekiaby N and Abdelaziz AI: Competing endogenous
RNAs in hepatocellular carcinoma-the pinnacle of rivalry. Semin
Liver Dis. 39:463–475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilczynska A and Bushell M: The complexity
of miRNA-mediated repression. Cell Death Differ. 22:22–33. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bitarte N, Bandres E, Boni V, Zarate R,
Rodriguez J, Gonzalez-Huarriz M, Lopez I, Javier Sola J, Alonso MM,
Fortes P, et al: MicroRNA-451 is involved in the self-renewal,
tumorigenicity, and chemoresistance of colorectal cancer stem
cells. Stem Cells. 29:1661–1671. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heng BC, Zhang X, Aubel D, Bai Y, Li X,
Wei Y, Fussenegger M and Deng X: An overview of signaling pathways
regulating YAP/TAZ activity. Cell Mol Life Sci. 78:497–512. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
R Core Team: (v3.14.0; 2016), . R: A
language and environment for statistical computing. R Foundation
for Statistical Computing; Vienna, Austria: https://www.gbif.org/tool/81287/r-a-language-and-environment-for-statistical-computingFebruary
10–2015
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Zhang B, Zhang H, Qi Y and Wang Y,
Wang W and Wang Y and Wang Y: E2F1-induced upregulation of long
non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell
progression by regulating miR-345-5p/COL6A3 pathway. Biochem
Biophys Res Commun. 512:150–155. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42D:D92–D97. 2014. View Article : Google Scholar
|
|
15
|
Dudekula DB, Panda AC, Grammatikakis I, De
S, Abdelmohsen K and Gorospe M: CircInteractome: A web tool for
exploring circular RNAs and their interacting proteins and
microRNAs. RNA Biol. 13:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Y, Yao Y, Zhong X, Leng K, Qin W, Qu L,
Cui Y and Jiang X: Downregulated circular RNA hsa_circ_0001649
regulates proliferation, migration and invasion in
cholangiocarcinoma cells. Biochem Biophys Res Commun. 496:455–461.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwarzenbacher D, Klec C, Pasculli B,
Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H,
Wulf-Goldenberg A, et al: miR-1287-5p inhibits triple negative
breast cancer growth by interaction with phosphoinositide 3-kinase
CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast
Cancer Res. 21:202019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui G, Zhao H and Li L: Long noncoding RNA
PRKCQ-AS1 promotes CRC cell proliferation and migration via
modulating miR-1287-5p/YBX1 axis. J Cell Biochem. 121:4166–4175.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji F, Du R, Chen T, Zhang M, Zhu Y, Luo X
and Ding Y: Circular RNA circSLC26A4 Accelerates Cervical Cancer
Progression via miR-1287-5p/HOXA7 Axis. Mol Ther Nucleic Acids.
19:413–420. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Tang L, Xu Y, Ge K, Huang J, Gu M,
Zhong J and Huang Q: mir-1287 suppresses the proliferation,
invasion, and migration in hepatocellular carcinoma by targeting
PIK3R3. J Cell Biochem. 119:9229–9238. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han TS, Hur K, Cho HS and Ban HS:
Epigenetic Associations between lncRNA/circRNA and miRNA in
Hepatocellular Carcinoma. Cancers (Basel). 12:26222020. View Article : Google Scholar
|
|
24
|
Mammoto A, Muyleart M, Kadlec A, Gutterman
D and Mammoto T: YAP1-TEAD1 signaling controls angiogenesis and
mitochondrial biogenesis through PGC1α. Microvasc Res. 119:73–83.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Landin-Malt A, Benhaddou A, Zider A and
Flagiello D: An evolutionary, structural and functional overview of
the mammalian TEAD1 and TEAD2 transcription factors. Gene.
591:292–303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Huang T, Zhang J, Wong CC, Zhang
B, Dong Y, Wu F, Tong JHM, Wu WKK, Cheng ASL, et al: TEAD1/4 exerts
oncogenic role and is negatively regulated by miR-4269 in gastric
tumorigenesis. Oncogene. 36:6518–6530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tome-Garcia J, Erfani P, Nudelman G,
Tsankov AM, Katsyv I, Tejero R, Bin Zhang, Walsh M, Friedel RH,
Zaslavsky E, et al: Analysis of chromatin accessibility uncovers
TEAD1 as a regulator of migration in human glioblastoma. Nat
Commun. 9:40202018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan Y, Gao Y, Rao J, Wang K, Zhang F and
Zhang C: YAP-1 promotes tregs differentiation in hepatocellular
carcinoma by enhancing TGFBR2 transcription. Cell Physiol Biochem.
41:1189–1198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Olesen UH, Bojesen S, Gehl J and
Haedersdal M: Anticancer drugs and the regulation of Hedgehog genes
GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell
lines. Anticancer Drugs. 28:1106–1117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qi C, Di Minin G, Vercellino I, Wutz A and
Korkhov VM: Structural basis of sterol recognition by human
hedgehog receptor PTCH1. Sci Adv. 5:eaaw64902019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the Hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qi X and Li X: Mechanistic insights into
the generation and transduction of hedgehog signaling. Trends
Biochem Sci. 45:397–410. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Laczko R and Csiszar K: Lysyl Oxidase
(LOX): Functional contributions to signaling pathways.
Biomolecules. 10:10932020. View Article : Google Scholar
|
|
34
|
Saatci O, Kaymak A, Raza U, Ersan PG,
Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari
SA, et al: Targeting lysyl oxidase (LOX) overcomes chemotherapy
resistance in triple negative breast cancer. Nat Commun.
11:24162020. View Article : Google Scholar : PubMed/NCBI
|
